Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study

A C K Larstorp, P M Okin, R B Devereux, M H Olsen, H Ibsen, B Dahlöf, Eigil Kjeldsen, K Wachtell

18 Citationer (Scopus)

Abstract

The predictive value of changes in the severity of electrocardiographic left ventricular hypertrophy (ECG-LVH) during antihypertensive therapy remains unclear in isolated systolic hypertension (ISH). In a Losartan Intervention For Endpoint reduction in hypertension substudy, we included 1320 patients aged 54-83 years with systolic blood pressure (BP) of 160-200 mm Hg, diastolic BP
OriginalsprogEngelsk
TidsskriftJournal of Human Hypertension
Vol/bind25
Udgave nummer3
Sider (fra-til)178-85
Antal sider8
ISSN0950-9240
DOI
StatusUdgivet - 1 mar. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study'. Sammen danner de et unikt fingeraftryk.

Citationsformater